Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Los Angeles Auto Show Announces Return of its Consumer Choice Awards - THE ZEVAS 2024
-
TinyGemsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Expands Cardiometabolic Health Solution with Twill Behavioral Health Integration for Enhanced Member Engagement
-
Alliance Trust PLC - Transaction In Own Shares
-
Premier: JIDU Unveils its Second Model - Robocar 07 Sedan
-
OCuSOFT® and Dr. Paul Karpecki Set the Record Straight on Retaine® MGD®
-
Imagine Learning Opens New Global HQ in Tempe
-
SEC Investor Advisory Committee to Discuss Investment Advice and Key Topics from Securities Litigation at Sept. 19 Meeting
-
Immuno-Oncology Researchers Have Leveraged $200,000 in Seed Grant Funding from Curebound to Secure $9.6M in NIH Follow-On Funding and Launch Clinical Trial for Head and Neck Cancer Immunotherapy
-
Curiosity Expands FAST Distribution with Samsung TV Plus
-
Redpanda Adds AI Integrations and Cloud Availability to Redpanda Connect; Unveils Vision for R1, the Multimodal Streaming Data Engine
-
Sheppard Pratt Welcomes Three New Chiefs of Medical Staff to Leadership Team
-
AM Best Affirms Credit Ratings of Toyota Motor Insurance Company
-
T-Mobile’s Network and Teams Ready for Hurricane Francine
-
Masimo’s Lawsuit Forced Politan and Quentin Koffey to Issue Corrective Disclosures on False and Misleading Statements Made to Masimo Stockholders on Issues Material to the Proxy Contest
-
Fanatics Sportsbook & Washington Spirit Launch Groundbreaking Partnership For Market Access in Washington, D.C.
-
Orveda, the French multi-award-winning biotech skincare brand, unveils LA MAISON ORVEDA NEW YORK CITY, a wellness sanctuary dedicated to glow and skin longevity, located in the heart of the Upper East
-
TechMediaBreaks – N2OFF Inc. (NASDAQ: NITO) Solar PV JV with Solterra Shows Potential for Increased Capacity
-
MetaEra Enters a New Era: Building a Non-Fungible Brand for You in Web3 World
-
Vranken-Pommery Monopole - Availability of the 2024 Half-Year Financial Report
-
Vranken-Pommery Monopole - 2024 Half Year Results - Current Operating income up 22.8%
-
Voltalia SA: Total number of shares and voting rights in the share capital as of August 31, 2024
-
SUSE Recognized as a Leader in 2024 Gartner® Magic Quadrant™ for Container Management
-
Graham Holdings Company Declares Regular Quarterly Dividend
-
Churchill Stateside Securities Acts as a Bond Underwriter for $21.5MM in Short-Term Cash Backed Tax-Exempt Bonds Sold in The Public Marketplace to Institutional Investors as Part of Affordable Housing
-
Fundraising screening of “A Girl Like Him” to support LGBTQ+ youth and end homelessness
-
Red Roof Inn Plus in Danville, KY: AW Properties Global Announces UCC Foreclosure Sale of 75% Membership Interest in LLC Holding Title to the Operational 48-Room Hotel
-
Pylontech US Showcases at RE+ 2024
-
Imerys recognizes CynerSorb® as a sustainable solution and Pioneer Product for the Renewable Diesel market
-
ChineseNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Receives Notification from NASDAQ Regarding Bid Price ‘Compliance Deficiency’
-
InvestorNewsBreaks – MetAlert Inc. (MLRT) Partners with American Rounds to Enhance Gun Safety with Innovative Technology
-
NFL Alumni & Giants Great Victor Cruz Team Up To Celebrate Hispanic Heritage Month
-
NFL Alumni & Giants Great Victor Cruz Team Up To Celebrate Hispanic Heritage Month
-
Pack Your LUNCH! Right: ProAmpac Unveils Award-Winning Food-to-Go Packaging Solutions at LUNCH! 2024
-
Stapokibart Was Granted Marketing Approval From National Medical Products Administration For The Treatment Of Moderate-to-severe Atopic Dermatitis in Adults
-
Abolis Biotechnologies Secures 35 Mio. Euro From International Consortium of Industrials and Funds
-
CIM Group Signs Southern California Gas Company to 198,553-Square-Foot Lease at City National 2CAL
-
LUB Liquidating Trust Declaration of Distribution of $0.10 Per Unit
-
City of Hope and Biopharmaceutical Research Company announce first patient has received BRC-001, a first-in-class cannabinoid therapeutic, in a clinical trial investigating supportive care in breast c
-
Volar Air Mobility and Etihad Aviation Training LLC Sign MoU to Collaborate on Advanced Electric Aircraft Operations
-
Illinois Treasurer Michael Frerichs Announces Enhancements To Bright Start 529 College Savings
-
HealthEZ Expands Team to Drive Growth and Continue Simplifying Healthcare
-
CSIOS President, Mr. Cesar Pie, Named One of HITEC’s 100 Most Influential Hispanic Executives in Technology for 2025
-
What to Know About Your First Credit Card
-
Yosemite Clean Energy Receives $300,000 Wood Innovations Grant From USDA Forest Service for Colorado Plant
-
Free Speech Network Wins Best TV Station for the Fourth Consecutive Year, Chosen by the People
-
Canto Acquires Image Relay
-
Peruvian Metals Provides Corporate Update and Announces Financing
-
Safe-Guard Products International Announces Key Leadership Appointments
-
Metabase Q Helps Risk Officers and CISOs Reduce Cybersecurity Risk With $11 Million in Series A Extension Funding
-
Ty J. Young Wealth Management Acquires Amatulli and Associates Financial Services
